TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $329 | +5.4% | 20,000 | 0.0% | 0.38% | -13.5% |
Q4 2022 | $312 | -99.9% | 20,000 | -55.6% | 0.44% | +7.9% |
Q3 2022 | $583,000 | -74.8% | 45,000 | -73.5% | 0.40% | -67.4% |
Q4 2021 | $2,310,000 | -51.5% | 169,500 | -41.7% | 1.24% | -44.0% |
Q3 2021 | $4,762,000 | +71.9% | 290,753 | +76.6% | 2.21% | +99.8% |
Q2 2021 | $2,770,000 | +47.3% | 164,610 | +59.8% | 1.11% | +57.8% |
Q1 2021 | $1,880,000 | +105.9% | 102,988 | +101.1% | 0.70% | +81.6% |
Q3 2020 | $913,000 | +234.4% | 51,200 | +184.4% | 0.39% | +85.6% |
Q1 2020 | $273,000 | – | 18,000 | +1799900.0% | 0.21% | – |
Q3 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
Q2 2019 | $38,000 | -97.8% | 2,200 | -97.4% | 0.01% | -98.1% |
Q1 2019 | $1,714,000 | +171300.0% | 84,146 | +140143.3% | 0.59% | – |
Q4 2018 | $1,000 | -100.0% | 60 | -100.0% | 0.00% | -100.0% |
Q3 2018 | $3,123,000 | +66.9% | 146,156 | +63.1% | 0.73% | -2.0% |
Q2 2018 | $1,871,000 | – | 89,600 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |